Landiolol: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Landiolol. Educational only — not medical advice.

Labeled uses

RAPIBLYK is indicated for the short-term reduction of ventricular rate in adults with supraventricular tachycardia including atrial fibrillation and atrial flutter, and pediatric patients with supraventricular tachycardia.

Source: FDA labeling via NIH DailyMed (set 27e7f20f…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.